Elevated Serum Levels of NSE and S-100β Correlate with Increased Risk of Acute Cerebral Infarction in Asian Populations

por Li, Ke, Jia, JianJun, Wang, ZhenFu, Zhang, ShanChun
Publicado 2015

Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngea...

por Wang, Fangzheng, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Quanquan, Sun, Tongxin, Liu, Zhenfu, Fu, Yangming, Jiang
Publicado 2020

The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma

por Yongfeng, Piao, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Zhenfu, Fu, Haitao, Jiang, Yangming, Jiang, Fangzheng, Wang
Publicado 2021

Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma

por Fangzheng, Wang, Chuner, Jiang, Lei, Wang, Weijun, Chen, Min, Xu, Quanquan, Sun, Tongxin, Liu, Aizawa, Rihito, Sakamoto, Masoto, Zhenfu, Fu
Publicado 2016

Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy: Single-cent...

por Fangzheng, Wang, Chuner, Jiang, Haiyan, Qin, Quanquan, Sun, Zhimin, Ye, Tongxin, Liu, Jiping, Liu, Peng, Wu, Kaiyuan, Shi, Zhenfu, Fu, Yangming, Jiang
Publicado 2019

Long-Term Use of Nimotuzumab in Combination With Intensity-Modulated Radiotherapy and Chemotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma: Experience...

por Fangzheng, Wang, Chuner, Jiang, Zhiming, Ye, Tongxin, Liu, Fengqin, Yan, Lei, Wang, Bin, Li, Fujun, Hu, Ming, Chen, Weifeng, Qin, Zhenfu, Fu
Publicado 2018

Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma

por Fangzheng, Wang, Quanquan, Sun, Chuner, Jiang, Zhimin, Ye, Shuangyan, Yang, Huanhuan, Yu, Jianfang, Shi, Sakamoto, Masoto, Weifeng, Qin, Zhenfu, Fu, Yangming, Jiang, Yuezhen, Wang
Publicado 2017

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma

por Fangzheng, Wang, Chuner, Jiang, Quanquan, Sun, Zhimin, Ye, Tongxin, Liu, Jiping, Liu, Sakamoto, Masoto, Peng, Wu, Kaiyuan, Shi, Weifeng, Qin, Zhenfu, Fu, Yangming, Jiang
Publicado 2017

Addition of chemotherapy to intensity-modulated radiotherapy does not improve survival in stage II nasopharyngeal carcinoma patients

por Fangzheng, Wang, Chuner, Jiang, Quanquan, Sun, Zhimin, Ye, Tongxin, Liu, Jiping, Liu, Sakamoto, Masoto, Peng, Wu, Kaiyuan, Shi, Weifeng, Qin, Zhenfu, Fu, Yangming, Jiang
Publicado 2018

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

por Fangzheng, Wang, Chuner, Jiang, Zhimin, Ye, Quanquan, Sun, Tongxin, Liu, Min, Xu, Peng, Wu, Bin, Long, Sakamoto, Masoto, Yuezhen, Wang, Fengqin, Yan, Zhenfu, Fu, Yangming, Jiang
Publicado 2017

Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advance...

por Fangzheng, Wang, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Quanquan, Sun, Tongxin, Liu, Min, Xu, Peng, Wu, Bin, Long, Aizawa, Rihito, Sakamoto, Masoto, Zhenfu, Fu
Publicado 2017

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcin...

por Fangzheng, Wang, Quanquan, Sun, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Tongxin, Liu, Min, Xu, Peng, Wu, Haitao, Jiang, Aizawa, Rihito, Sakamoto, Masoto, Yuezhen, Wang, Zhenfu, Fu
Publicado 2017